Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0873-2022

Drug recall · May 25, 2022

Accupril recall

Why: CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Accupril (Quinapril HCl Tablets) 20 mg, 90 Tablets, Rx only NDC 0071-0532-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017

Lots / codes

Lots: DX8682 Exp. MAR 31 2023; DG1188 Exp. MAR 31 2022

Quantity
10,304 bottles
Company
Pfizer Inc., New York, NY
Distribution
Nationwide and Puerto Rico
Initiated
April 22, 2022 · Voluntary: Firm initiated
Classified
May 16, 2022
Reported
May 25, 2022
Ended
October 5, 2023
How notified
Press Release

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Quinapril

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.